Posters
« Back
Repurposing Drugs for the Treatment of Multi-Drug Resistant Breast Cancer
EP20244
Poster Title: Repurposing Drugs for the Treatment of Multi-Drug Resistant Breast Cancer
Submitted on 19 Dec 2013
Author(s): David Monaghan, Rachel Griffin, Amie Regan, Enda O’Connell, Howard Fearnhead
Affiliations: National University of Ireland, Galway
Poster Views: 1,706
View poster »


Poster Information
Abstract: In this study, the Johns Hopkins Clinical Compound Library, containing approximately 1,500 FDA and foreign-approved clinical compounds, was used to screen a multi-drug resistant, triple negative breast cancer cell line for drug sensitivity.Summary: In this study, the Johns Hopkins Clinical Compound Library, containing approximately 1,500 FDA and foreign-approved clinical compounds, was used to screen a multi-drug resistant, triple negative breast cancer cell line for drug sensitivity.Report abuse »
Creative Commons

Related Posters


miniaturization and automation of CEL-Seq2 and SMART-Seq2 using the mosquito liquid handler
Josip Herman1, Jon Penterman2, Sagar1, Andreas Diefenbach3, Antigoni Triantafyllopoulou4, Anne F. Hammerstein5, Joby Jenkins5, Dominic Grün1, Stuart S. Levine2 and Klaus Hentrich5

Delivery of RNP complexes for CRISPRi (dCas9) silencing in vitro and in vivo using crystalline ultrasmall particles (CUSP)
GM Unger*, VL Korman, BT Kren, DL Tobolt

Genetic Engineering in Male Sterility for Hybrid Variety Development
Abir Hasan Joy

Platinum™ II Taq Hot-Start DNA Polymerase: PCR simplified with universal annealing
Skaistė Valinskytė, Edita Elijošiūtė, Tomas Radzvilavičius, Miglė Mikutėnaitė, Jonas Belevičius, Aistė Serapinaitė, Rasa Sukackaitė

Single-use technology in the production of DNA-free Taq DNA polymerase
Kęstutis Bargaila, Vytautas, Budrys, Andrius Krasauskas, Dovilė Lisauskienė, Milda Romeikaitė, Sonata J.-Urbanavičienė, and Juozas Šiurkus